Advanced prosthetic systems are redefining possibilities in vision restoration for patients with profound sight loss. Artificial vision and retinal implants explore the development and clinical use of visual prostheses designed to stimulate viable retinal or cortical structures. These systems often integrate external image capture with implanted microelectrode arrays that relay signals to the brain, enabling perception of light, motion, and basic shapes. Though current devices offer limited resolution, they can significantly improve environmental awareness and mobility. Ongoing research in optogenetic stimulation, wireless subretinal arrays, and cortical implants aims to enhance image clarity and user experience. Functional success also depends on post-implant rehabilitation and the brain's ability to adapt to artificial input. As the field progresses, collaboration between neuroscientists, engineers, and ophthalmologists is key to refining these technologies and expanding their clinical impact for patients with irreversible retinal conditions.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom